RPL7AP69

Across TCGA pan-cancer cohorts, RPL7AP69 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RPL7AP69 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPL7AP69 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL7AP69 expression acts as an unfavorable survival marker, although some lineages such as OV and UCEC show a favorable association.

KIRC, LIHC, and ACC are the cancer types where RPL7AP69 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.512	0.665	<.001	94	view →
LIHC	OS	Tertile	II,III,IV	0.293	0.628	.003	90	view →
ACC	DFS	Tertile	All	0.156	0.791	<.001	39	view →
OV	OS	Tertile	All	0.448	0.302	.006	30	view →
THCA	OS	Tertile	II,III,IV	0.171	0.824	<.001	27	view →
LUSC	DFS	Tertile	III,IV	0.079	0.751	.024	18	view →
UCEC	DFS	Tertile	II,III,IV	0.822	0.434	.036	12	view →
LUAD	OS	Tertile	III,IV	1.000	0.275	.046	9	view →
READ	DFS	Tertile	IV	0.255	0.628	.020	9	view →
SKCM	DFS	Tertile	II,III,IV	0.762	0.541	.034	3	view →
STAD	OS	Quartile	III,IV	0.410	0.560	.039	2	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RPL7AP69–KIRC (OS)

Open the KIRC breakdown →